The CVS Health Corporation stock showcases a stable position within the healthcare sector. With a broad spectrum of services ranging from health insurance to retail pharmacy, CVS’s balanced approach provides resiliency, albeit with modest growth expectations due to market competition. Investors should consider both the defensive nature and the economic pressures on pricing and margins.
The overall fundamental rating for CVS Health Corporation is solid, indicating a well-balanced financial position, although certain areas like debt management require attention.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 2 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 4 |
Evaluating CVS's historical performance helps to identify trends and potential improvements or areas of concern.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-10-31 | 3 | 5 | 2 | 4 | 1 | 1 | 4 |
| Previous Period | 0 | 5 | 2 | 4 | 1 | 1 | 4 |
Recent analyst forecasts suggest a positive outlook for CVS, with price targets indicating potential appreciation.
| High | Low | Median | Consensus |
|---|---|---|---|
| 103 | 82 | 91 | 91.22 |
With a consensus rating of 'Buy,' CVS garners significant support from analysts, with few expecting underperformance.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 32 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
CVS Health Corporation demonstrates a robust position in the healthcare sector with a diverse product and service line-up. While fundamental ratings highlight some areas for improvement, particularly in debt management, the stock holds potential for stable returns. Analyst sentiment largely favors a 'Buy' stance, supported by positive price targets. Investors should weigh these factors alongside broader economic conditions and competitive pressures within the industry.